UHS

23 capabilities Verified Oct 2026 One of 2,018 in United Kingdom
Send Enquiry

Send one structured enquiry and we chase the reply for you. No cold email, no chasing.

Details

Wessex Regional Genetics Laboratory, Salisbury District Hospital, Odstock Road
Salisbury SP2 8BJ , United Kingdom

Accreditation

Active UKAS 9005
uhs.nhs.uk Prefer to enquire through us? Send an enquiry

Accreditation Details

Accreditation Body

UKAS

Number

9005

Status

Active

Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.

Download Scope PDF

Test Capabilities (23)

Standard Reference Description Category
(1A) (ii) genotyping of specific mutations and genomic regions for both constitutional and acquired conditions[as per definitive list] (2A) (1A) (ii) genotyping of specific mutations and genomic regions for both constitutional and acquired conditions[as per definitive list] (2A) Molecular Diagnostics / PCR
D816V mutation D816V mutation Molecular Diagnostics / PCR
Detection of cryptic chromosome rearrangements in acute leukaemia Detection of cryptic chromosome rearrangements in acute leukaemia Molecular Diagnostics / PCR
Molecular Genetics Molecular Genetics Molecular Diagnostics / PCR
Molecular genetic examinations for the purpose of clinical diagnosis Molecular genetic examinations for the purpose of clinical diagnosis Molecular Diagnostics / PCR
Qualitative detection of the KIT Qualitative detection of the KIT Molecular Diagnostics / PCR
Screening for unknown somatic variants in myeloid disorders in multi-gene fixed panel Illumina Screening for unknown somatic variants in myeloid disorders in multi-gene fixed panel Illumina Molecular Diagnostics / PCR
TruSight Myeloid Panel (1B) TruSight Myeloid Panel (1B) Molecular Diagnostics / PCR
CD138 cell separation for Multiple CD138 cell separation for Multiple Other
Clinical Cytogenetics: Detection of aneuploidy, maternal cell contamination and confirmation of genetic sex Clinical Cytogenetics: Detection of aneuploidy, maternal cell contamination and confirmation of genetic sex Other
Confirmation of genomic rearrangements detected using alternative technologies [as per definitive list] Confirmation of genomic rearrangements detected using alternative technologies [as per definitive list] Other
Confirmation of genomic rearrangements detected using alternative technologies. Family follow-up studies Confirmation of genomic rearrangements detected using alternative technologies. Family follow-up studies Other
Cytogenetics examinations for the purpose of clinical diagnosis Cytogenetics examinations for the purpose of clinical diagnosis Other
Detection and analysis of genomic rearrangements and imbalances Detection and analysis of genomic rearrangements and imbalances Other
Detection of acquired chromosome rearrangements from patients with haemato-oncology disorders[as per definitive list] Detection of acquired chromosome rearrangements from patients with haemato-oncology disorders[as per definitive list] Other
Detection of chromosome abnormalities associated with: Reproductive disorders Detection of chromosome abnormalities associated with: Reproductive disorders Other
Detection of chromosome rearrangements in comparison with considered normal pattern (ISCN) Detection of chromosome rearrangements in comparison with considered normal pattern (ISCN) Other
Haemato-oncology disorders Haemato-oncology disorders Other
Myeloma Myeloma Other
Sex chromosome disorders Sex chromosome disorders Other
Sizing analysis haemato-oncology disorders (bone marrow and whole blood only) Sizing analysis haemato-oncology disorders (bone marrow and whole blood only) Other
[as per definitive list] [as per definitive list] Other
[as per definitive list] (2B) [as per definitive list] (2B) Other

Send an Enquiry

Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.

Please select a test method from the list
Report incorrect or outdated information
0 labs selected
Compare